IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression.

Journal: Cell

Published: 2020-08-17

DOI: 10.1016/j.cell.2020.07.038

Affiliations: 27

Authors: 39

Go to article
Institutions Share
German Consortium of Translational Cancer Research (DKTK), Germany 0.24
Division of Molecular Genetics, DKFZ, Germany 0.13
Heidelberg University Hospital at Medical Faculty Heidelberg, Uni Heidelberg, Germany 0.08
Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Germany 0.08
Jena University Language and Information Engineering Laboratory (JULIE Lab), FSU, Germany 0.06
Department of Cell Toxicology, UFZ, Germany 0.05
National Center for Tumor Diseases (NCT) Heidelberg, Germany 0.05
Berlin Institute of Health (BIH), Germany 0.05
Faculty of Biosciences, Uni Heidelberg, Germany 0.05
Department of Ecological Chemistry, UFZ, Germany 0.03
Division of Biostatistics, DKFZ, Germany 0.03
Centre for Organismal Studies (COS Heidelberg), Uni Heidelberg, Germany 0.03
Department of Neuropathology at Medical Faculty Heidelberg, Uni Heidelberg, Germany 0.02
Clinical Cooperation Unit Neuropathology, DKFZ, Germany 0.02
Institute for Pharmacy and Molecular Biotechnology (IPMB), Uni Heidelberg, Germany 0.01
Institut für Organische Chemie, TUBAF, Germany 0.01
Leibniz Institute for Natural Product Research and Infection Biology - Hans-Knöll-Institute (HKI), Germany 0.01
Helmholtz Centre for Environmental Research (UFZ), Germany 0.01
Mohammed VI Polytechnic University, Morocco 0.01
School of Medicine, UCR, Costa Rica 0.01
Institute of Biochemistry, LFU, Austria 0.01
Center for Molecular Biosciences Innsbruck (CMBI), LFU, Austria 0.01
Department of Pediatrics, RUG, Netherlands 0.01
Department of Neuroscience, University of Oldenburg, Germany 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER